Facility to democratize access to world-class scale-up infrastructure; over Rs.200 crore in upgrades planned
Hyderabad, November 24, 2025 – The inauguration of 1 Bio at Genome Valley marks a defining moment in India’s biologics and next-generation therapeutics journey, representing a major leap in democratizing access to world-class scale-up infrastructure.
The state-of-the-art facility will enable innovators to move from discovery to pilot and clinical readiness with greater speed, predictability, and affordability, positioning India as a global hub for biologics development.
Genome Valley’s 25-Year Milestone
As Genome Valley completes 25 years, the unveiling of its new identity and vision reflects Telangana’s commitment to shaping the next era of research-driven biotech leadership.
The launch of the Thermo Fisher-partnered Bioprocess Design Centre, along with plans for over Rs.200 crore in infrastructure upgrades, sets the foundation for Genome Valley’s next wave of global competitiveness.
World-Class Infrastructure
The 1 Bio facility provides critical infrastructure that has historically been a bottleneck for Indian biotech innovators. By offering accessible scale-up capabilities, the facility bridges the gap between laboratory research and commercial production, enabling:
- Faster time-to-market for biologics
- Reduced costs for clinical trials
- Improved access to pilot-scale manufacturing
- Enhanced collaboration between research and industry
Strategic Partnerships
The Thermo Fisher collaboration brings international expertise and cutting-edge bioprocessing technology to Genome Valley, creating a center of excellence that rivals global standards.
This partnership ensures that Indian researchers and companies have access to the same tools and methodologies used by leading biotech firms worldwide.
Infrastructure Upgrades
The planned Rs.200+ crore investment in infrastructure will include:
- Cutting-edge bioprocessing capabilities
- Improved connectivity within the cluster
- A landmark gateway structure symbolizing Genome Valley’s evolution
- Enhanced research and development facilities
- Modern amenities for the growing biotech workforce
Global Competitiveness
Strengthening this cluster with cutting-edge capability, improved connectivity, and landmark infrastructure ensures that Telangana remains at the forefront of life sciences innovation for decades to come.
Genome Valley has already established itself as a major biotech hub, hosting numerous pharmaceutical companies, research institutions, and vaccine manufacturers. The addition of 1 Bio and associated upgrades positions it to compete with leading global life sciences clusters.
Future-Ready Ecosystem
The facility represents Telangana’s vision of creating a comprehensive ecosystem that supports the entire biologics value chain—from basic research to commercialization—all within a single geographic cluster.
This integrated approach reduces barriers for innovators, accelerates development timelines, and positions Indian biotech companies to compete effectively in the global marketplace.
With the inauguration of 1 Bio and the ambitious upgrades planned for Genome Valley, Telangana is poised to lead India’s next generation of biologics and therapeutics innovation.
